The longevity of anti NSP antibodies and the sensitivity of a 3ABC ELISA - A 3 years follow up of repeatedly vaccinated dairy cattle infected by foot and mouth disease virus.

Vet Microbiol

Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, POB 12, Rehovot 76100, Israel. Electronic address:

Published: July 2015

ELISA tests for detection of anti NSP antibodies are extensively used in surveys estimating exposure of livestock to foot and mouth disease virus as a part of endemic and post epidemic surveillance programs. Yet, estimation of the longevity of anti NSP antibodies in naturally infected cattle and the sensitivity of ELISA tests based on them were rarely studied to date. Our research aim was to estimate the long term (up to 1118 days after exposure) change in levels of anti NSP antibodies in dairy cattle individuals naturally infected by FMDV and to evaluate the sensitivity of a commercially available ELISA kit in detecting anti NSP antibodies during the follow up period. A 3ABC blocking ELISA kit (PrioCHECK(®) FMDV NS) was used in a 3 years follow up study of repeatedly vaccinated cattle, which were found to be NSP positive during an FMD outbreak in a dairy farm. In order to rule out the possibility of a recurrent FMD outbreak involving the study population we combined clinical and laboratory monitoring: Cattle which were located in the same herd and were previously found as negative to anti NSP antibodies were followed and did not present FMD symptoms or a serological conversion. The overall sensitivity for infection detection was calculated using two approaches. When a conservative approach was taken and equivocal results (45%≤PI≤55%) were treated as negative, the sensitivities were 95% (CI95%=75.1-99.9%), 88.2% (CI95%=63.6-98.5%) and 76.9% (CI95%=46.2-95%) 311, 689 and 1118 days after the outbreak, respectively. However, when equivocal results were treated as positive, the sensitivities were 100% (CI95%=83.2-100%), 94.1% (CI95%=71.3-99.9%) and 92.3% (CI95%=64-99.8%) 311, 689 and 1118 days after the outbreak, respectively. We therefore conclude that this test can serve as a valuable tool for detection of previous FMDV infection in cattle in endemic countries, where routine vaccinations are implied, even several years after exposure.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vetmic.2015.04.003DOI Listing

Publication Analysis

Top Keywords

anti nsp
24
nsp antibodies
24
1118 days
12
longevity anti
8
years follow
8
repeatedly vaccinated
8
dairy cattle
8
foot mouth
8
mouth disease
8
disease virus
8

Similar Publications

Background: The use of enzymes within pig feed can reduce the challenges associated with antibiotic-free animal feeding. However, this enzymatic effect is often limited by the internal and external gut environment. This study aimed to improve diet quality and assess the impact of an enzymatically hydrolyzed diet (EHD) on growth performance, meat quality, and intestinal health in growing pigs.

View Article and Find Full Text PDF

Lycorine esters exert anti-HCoV-OC43 effect through reversibly acylating cysteine residue in the nsp 12 NiRAN domain.

Bioorg Chem

January 2025

State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China. Electronic address:

By introducing ester warheads into the hydroxyl groups in lycorine (1), three types of lycorine mono-ester or di-ester analogues were synthesized and evaluated for their antiviral activities against HCoV-OC43. Most of them showed higher selective indexes (SI) than 1, up to nearly 14 times. Using compound 6b as a probe, we firstly demonstrated that lycorine esters directly targeted nidovirus RdRp-associated nucleotidyltransferase (NiRAN) domain in the non-structural protein 12 (nsp 12) by reversibly acylating Cys12 to induce the shrink of NiRAN pocket and block the viral replication, different from the known RdRp inhibitors.

View Article and Find Full Text PDF

Targeting PD-1 T cells with small-format immunocytokines enhances IL-12 antitumor activity.

Mol Ther

January 2025

DNA and RNA Medicine Division, Cima Universidad de Navarra, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA) and CCUN, 31008 Pamplona, Spain. Electronic address:

Immunostimulatory cytokines and immune checkpoint inhibitors hold promise as cancer therapeutics; however, their use is often limited by reduced efficacy and significant toxicity. In this study, we developed small-format immunocytokines (ICKs) based on interleukin-12 (IL-12) and blocking nanobodies (Nbs) targeting mouse and human programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1). Both PD-1- and PD-L1-targeted ICKs demonstrated similar in vitro performance, significantly increasing IL-12 tethering to immune cells and enhancing T cell cytotoxic activity compared with IL-12 alone.

View Article and Find Full Text PDF

Ethnopharmacological Relevance: Niuhuang Shangqing Pill (NSP) is a renowned Chinese medicine prescription listed in the Chinese Pharmacopoeia (Edition, 2020; volume 1) and is utilized in clinical practice for treating headaches and acute pharyngitis (AP) associated with "Shanghuo". Despite its widespread use, the pharmacological mechanism and bioactive components underlying NSP in treating AP remain unclear.

Aim Of The Study: This study delved into evaluate the alleviation effect of NSP on AP and explore the mechanisms by analyzing multi-omics.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the effects of Neosetophomone B (NSP-B), a fungal metabolite, on T-cell acute lymphoblastic leukaemia (T-ALL) cells, highlighting its anti-cancer properties.
  • NSP-B was found to significantly inhibit T-ALL cell growth by causing cell cycle arrest and promoting apoptosis, while also deactivating the crucial PI3K/AKT/mTOR signalling pathway.
  • Importantly, NSP-B showed selectivity by reducing proliferation in activated T cells without affecting normal T cells, indicating its potential as a targeted therapy for T-ALL.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!